Manufacturer
28 recalls in our database name West-ward Pharmaceutical Corp. as the manufacturing or recalling firm.
Of the 28 recalls from West-ward Pharmaceutical Corp. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (29%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
West-Ward Pharmaceutical Corp. is recalling Fentanyl Citrate Injection due to failed impurities and degradation specifications. The recall covers 14,649 cartons distributed nationwide.
West-Ward Pharmaceutical Corp. is recalling 5,596 bottles of Ethambutol Hydrochloride Tablets, USP, 100 mg, due to an out-of-specification stability result.
West-Ward Pharmaceutical Corp. is recalling Isoniazid Tablets, USP, 300 mg because stability lots failed to meet dissolution specifications.
West-Ward Pharmaceutical Corp. is recalling 20,534 bottles of Carisoprodol Tablets, USP 350 mg, because heavy metals and inactive components were visually observed during routine stability testing.
West-Ward Pharmaceutical Corp. is recalling Irinotecan Hydrochloride Injection because an incorrect calculation resulted in an assay higher than the labeled claim.
West-Ward Pharmaceutical Corp. is recalling Irinotecan Hydrochloride Injection because a calculation error resulted in drug levels higher than labeled.
West-Ward Pharmaceutical Corp. is recalling Belladonna Alkaloids with Phenobarbital Tablets because black specks of degraded organic material were found on the tablets.
West-Ward Pharmaceutical Corp. is recalling 51,704 bottles of Lisinopril Tablets, USP, 2.5 mg because they failed impurity specifications at the 48-month time point.
West-Ward Pharmaceutical Corp. is recalling 118 bottles of Ethambutol Hydrochloride Tablets 400 mg due to out-of-specification surface ink defects.
West-Ward Pharmaceutical Corp. is recalling Belladonna Alkaloids with Phenobarbital Tablets because they contain a trace amount of Methocarbamol.
West-Ward Pharmaceutical Corp. is recalling specific lots of Belladonna Alkaloids with Phenobarbital Tablets due to the presence of black specks comprised of degraded organic material.
West-ward Pharmaceutical Corp. is recalling specific lots of Nicardipine Hydrochloride Injection because they failed impurity specifications for a degradation product.
West-ward Pharmaceutical is recalling 1,258 bottles of Donnatal Extentabs because the bottles are labeled with an expiration date of April 2015 instead of the correct April 2013.
West-Ward Pharmaceutical Corp. is recalling 3,061 bottles of Ethambutol Hydrochloride Tablets due to out-of-specification assay results.
West-ward Pharmaceutical Corp. is recalling Ciprofloxacin 500 mg tablets due to a complaint of rubber-like material found in a tablet.
West-ward Pharmaceutical Corp. is recalling 1,763 bottles of Carisoprodol Tablets, 350 mg, because they lack the required C-IV imprint on the label.
West-ward Pharmaceutical Corp. is recalling VersaPharm Ethambutol Tablets USP 400 mg because the tablet cores may be discolored.
West-ward Pharmaceutical Corp. is recalling Isoniazid Tablets 300 mg due to failed dissolution specifications and a 36-month stability timepoint issue.
West-ward Pharmaceutical Corp. is recalling Belladonna Alkaloids with Phenobarbital tablets because uncharacteristic black spots were found in the product.
West-ward Pharmaceutical Corp. voluntarily recalled 1,185 bottles of Glycopyrrolate Tablets, USP, 1 mg, in Ohio due to subpotent drug content.
West-ward Pharmaceutical Corp. is recalling specific lots of PredniSONE Tablets, USP, 10 mg, due to the presence of gray defects in the tablets.
West-ward Pharmaceutical Corp. is recalling 8,585 bottles of Carisoprodol Tablets, USP, 350 mg, due to the presence of uncharacteristic black spots on the tablets.
West-ward Pharmaceutical Corp. is recalling specific lots of Lisinopril Tablets, USP 40 mg, because uncharacteristic black spots were found in the tablets.
West-ward Pharmaceutical Corp. is recalling specific lots of Lisinopril and Hydrochlorothiazide Tablets because they contain minute stainless steel particulates.
West-ward Pharmaceutical Corp. is recalling specific lots of Propylthiouracil Tablets, USP, 50 mg because uncharacteristic spots identified as steel corrosion, degraded tablet material, and hydrocarbon oil were found.